机构

• 高能物理研究所 [100]
• 成都生物研究所 [58]
• 物理研究所 [41]
• 上海药物研究所 [41]
• 近代物理研究所 [38]
• 西北高原生物研究所 [30]
• 更多

采集方式

• OAI收割 [407]
• iSwitch采集 [101]

内容类型

• 期刊论文 [502]
• 会议论文 [6]

发表日期

• 2024 [2]
• 2023 [7]
• 2022 [16]
• 2021 [20]
• 2020 [16]
• 2019 [53]
• 更多

学科主题

• Chemistry [17]
• 天然产物研究 [8]
• Pharmacolo... [6]
• Chemistry,... [5]
• Physics [5]
• Biochemist... [3]
• 更多

筛选

浏览/检索结果: 共508条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Identifying a non-conserved site for achieving allosteric covalent inhibition of CECR2 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2025, 页码: 16 作者:  Tang, Cai-ling;  Li, Yuan-qing;  Du, Xi-kun;  Fang, Xiao-xia;  Guang, Yi-man   |  收藏  |  浏览/下载：9/0  |  提交时间：2025/04/01 dynamics simulation  CECR2  covalent inhibitor  allosteric effect   Application of N-doped NiCo2O4/NiO/Co3O4 composites rich in oxygen vacancies in electromagnetic wave absorption 期刊论文  OAI收割 NANOTECHNOLOGY, 2024, 卷号: 35 作者:  Li, Junkang;  Yang, Yiqing;  Ma, Yongqing;  Zhu, Chuhong;  Wang, Meiling   |  收藏  |  浏览/下载：3/0  |  提交时间：2024/11/20 NiCo2O4/NiO/Co3O4 composites  N-doped  oxygen vacancy  microwave absorption   Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 11 作者:  Song, Pei-ran;  Wan, Zhi-peng;  Huang, Ge-ge;  Song, Zi-lan;  Zhang, Tao   |  收藏  |  浏览/下载：64/0  |  提交时间：2024/07/12 diffuse large B-cell lymphoma  BTK inhibitors  drug resistance  BTK C481F  BTK A428D  SYHA1813   The claim of primacy of human gut Bacteroides ovatus in dietary cellobiose degradation 期刊论文  OAI收割 GUT MICROBES, 2023, 卷号: 15, 期号: 1, 页码: 18 作者:  Li, Meixia;  Wang, Yeqing;  Guo, Ciliang;  Wang, Sheng;  Zheng, Liangzhen   |  收藏  |  浏览/下载：74/0  |  提交时间：2023/10/17 Human gut microbiota  cellobiose  bacteroide ovatus  cellulase  structure   Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 24, 页码: 16694-16703 作者:  Fu, Yixian;  Huang, Yahui;  Zhou, Chenchen;  Li, Xinge   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/01/26 Carbon mineralization and abiotic methane synthesis within fluid inclusions in mafic minerals from postcollisional pyroxenite 期刊论文  OAI收割 GEOCHIMICA ET COSMOCHIMICA ACTA, 2023, 卷号: 356, 页码: 38-50 作者:  Zhang, Long;  Wang, Qiang;  Xian, Haiyang;  Zhou, Jin-Sheng;  Ding, Xing   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/08/23 Carbon mineralization  Methane  Fluid inclusions  Mafic minerals  Pyroxenite  Dabie orogen   A Spectral-timing Study of the Inner Flow Geometry in MAXI J1535-571 with Insight-HXMT and NICER 期刊论文  OAI收割 ASTROPHYSICAL JOURNAL, 2023, 卷号: 953, 期号: 2, 页码: 12 作者:  Yu, Wei;  Bu, Qing-Cui;  Liu, He-Xin;  Huang, Yue;  Zhang, Liang   |  收藏  |  浏览/下载：24/0  |  提交时间：2023/11/14 Incorporation of a Boron-Nitrogen Covalent Bond Improves the Charge-Transport and Charge-Transfer Characteristics of Organoboron Small-Molecule Acceptors for Organic Solar Cells 期刊论文  OAI收割 MOLECULES, 2023, 卷号: 28, 期号: 2, 页码: 15 作者:  Yang, Jie;  Ding, Wei-Lu;  Li, Quan-Song;  Li, Ze-Sheng   |  收藏  |  浏览/下载：0/0  |  提交时间：2023/05/19 organoboron  non-fullerene acceptor-based organic solar cells  density functional theory  charge transport  charge transfer   Federated Learning with Privacy-preserving and Model IP-right-protection 期刊论文  OAI收割 Machine Intelligence Research, 2023, 卷号: 20, 期号: 1, 页码: 19-37 作者:  Qiang Yang;  Anbu Huang;  Lixin Fan;  Chee Seng Chan;  Jian Han Lim   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/04/23 Federated learning  privacy-preserving machine learning  security  decentralized learning  intellectual property protection   Prebiotic-Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health 期刊论文  OAI收割 SMALL STRUCTURES, 2023, 页码: 2200312 作者:  Cui,Jin-Jin;  Li,Rui;  Ma,Xiao-Lei;  Yu,Hao-Yang;  Luo,Zhi-Gang   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/07/30 atorvastatin  gut flora  nanoamorphous  nonalcoholic fatty liver disease  prebiotics  SOLID DISPERSIONS  STATIN USE  EFFICACY  STEATOHEPATITIS  FORMULATION  SAFETY  ABSORPTION  ACTIVATION  MICROBIOTA  CIRRHOSIS